Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Solid Tumors.
Status:
Not yet recruiting
Trial end date:
2024-09-01
Target enrollment:
Participant gender:
Summary
The purpose of current study is to evaluate the efficacy and safety of hetrombopag for the
treatment of chemotherapy-induced thrombocytopenia in patients with solid tumors.